dr. agarwal on pfs2 data from the titan trial in mcspc
Published 4 years ago • 116 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:28
apalutamide plus adt leads to survival benefit in mcspc
-
1:37
dr. agarwal on the talapro-2 trial in mcrpc
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
3:06
titan trial
-
7:52
does high psa levels = prostate cancer? | dr steven tucker
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
1:01:33
prostate cancer follow-up care: one size doesn’t fit all
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
31:13
titan trial | investigating the addition of apalutamide to androgen deprivation therapy
-
1:20
nancy a. dawson, md, discusses outcomes from the titan study in mcspc
-
2:11
tomasz m. beer md, facp, discusses outcomes from the titan study in mcspc
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
0:56
dr. choudhury on the designs of key trials in nonmetastatic crpc
-
2:36
advanced prostate cancer treatment – if, when and what?
-
2:18
dr. mirza on final data of the nsgo-avanova2/engot-ov24 trial in ovarian cancer
-
2:19
find the right lens for cataract treatment
-
5:56
card trial in metastatic crpc
-
1:44
dr. agarwal on the stampede and latitude trials for prostate cancer
-
1:26
dr. agarwal on potential agents for metastatic hormone-sensitive prostate cancer
-
4:31
applying clinical trial data for treatment of mrcc
-
30:20
clinical trials in genitourinary cancers: magnitude, proof 302, cytoshrink